Filed: 8/8/2023ACC: 0000950123-23-006845
📋 What this filing means
INTERNATIONAL BIOTECHNOLOGY TRUST PLC filed this quarterly 13F‑HR report disclosing 61 equity positions with a total reported market value of $328.50M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
61
Positions
$328.50M
Total AUM (reported)
8.86M
Total Shares
Allocation by class
COM$290.41M88.4%
CL A$15.64M4.8%
SHS$7.07M2.2%
SPONSORED ADS$4.36M1.3%
COM NEW$3.81M1.2%
ADR$2.19M0.7%
SHS USD$2.13M0.6%
Portfolio Concentration
Top 3$68.40M20.8%
4–10$100.92M30.7%
11–25$100.37M30.6%
Rest$58.81M17.9%
Top 3 weight
20.8%
Top 10 weight
51.5%
Voting Authority Distribution
Total shares with voting rights: 8.86M
Sole
Full voting authority
8.86M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole61
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings61
Rows:
AMGEN INC COM
SOLEShares117.25K
TypeSH
Market value$26.03M
7.92%
Sole
117.25K
Shared
0.00
None
0.00
INCYTE CORP
SOLEShares358.45K
TypeSH
Market value$22.30M
6.79%
Sole
358.45K
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS
SOLEShares570.50K
TypeSH
Market value$20.07M
6.11%
Sole
570.50K
Shared
0.00
None
0.00
REGENERON PHARMS.
SOLEShares27K
TypeSH
Market value$19.40M
5.91%
Sole
27K
Shared
0.00
None
0.00
SUPERNUS PHARMS.
SOLEShares523.50K
TypeSH
Market value$15.74M
4.79%
Sole
523.50K
Shared
0.00
None
0.00
VERA THERAPEUTICS
SOLEShares975.23K
TypeSH
Market value$15.64M
4.76%
Sole
975.23K
Shared
0.00
None
0.00
ALNYLAM PHARMS.
SOLEShares81.60K
TypeSH
Market value$15.50M
4.72%
Sole
81.60K
Shared
0.00
None
0.00
APELLIS PHARMS.
SOLEShares129.70K
TypeSH
Market value$11.81M
3.60%
Sole
129.70K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares52.76K
TypeSH
Market value$11.65M
3.55%
Sole
52.76K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES
SOLEShares176.86K
TypeSH
Market value$11.18M
3.40%
Sole
176.86K
Shared
0.00
None
0.00
GILEAD SCIENCES
SOLEShares144.58K
TypeSH
Market value$11.14M
3.39%
Sole
144.58K
Shared
0.00
None
0.00
ILLUMINA INC
SOLEShares50.50K
TypeSH
Market value$9.46M
2.88%
Sole
50.50K
Shared
0.00
None
0.00
MIRATI THERAPEUTICS INC
SOLEShares260K
TypeSH
Market value$9.39M
2.86%
Sole
260K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares21K
TypeSH
Market value$7.39M
2.25%
Sole
21K
Shared
0.00
None
0.00
REVANCE THERAPEUTICS INC
SOLEShares288.73K
TypeSH
Market value$7.30M
2.22%
Sole
288.73K
Shared
0.00
None
0.00
HORIZON THERAPEUTICS
SOLEShares67K
TypeSH
Market value$6.89M
2.10%
Sole
67K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares441.02K
TypeSH
Market value$6.77M
2.06%
Sole
441.02K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES
SOLEShares68.88K
TypeSH
Market value$6.49M
1.98%
Sole
68.88K
Shared
0.00
None
0.00
KARUNA THERAPEUTICS INC
SOLEShares25.70K
TypeSH
Market value$5.57M
1.69%
Sole
25.70K
Shared
0.00
None
0.00
AURINIA PHARMACEUTICALS INC
SOLEShares573.53K
TypeSH
Market value$5.55M
1.69%
Sole
573.53K
Shared
0.00
None
0.00
DENALI THERAPEUTICS
SOLEShares188K
TypeSH
Market value$5.54M
1.69%
Sole
188K
Shared
0.00
None
0.00
KRYSTAL BIOTECH
SOLEShares45.95K
TypeSH
Market value$5.39M
1.64%
Sole
45.95K
Shared
0.00
None
0.00
BIOMARIN PHARM.
SOLEShares58.66K
TypeSH
Market value$5.08M
1.55%
Sole
58.66K
Shared
0.00
None
0.00
MADRIGAL PHARMS.
SOLEShares18.30K
TypeSH
Market value$4.23M
1.29%
Sole
18.30K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS
SOLEShares58.30K
TypeSH
Market value$4.19M
1.27%
Sole
58.30K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AMGEN INC COMSOLE | COM | 117.25K | SH | $26.03M 7.92% | 117.25K | 0.00 | 0.00 |
INCYTE CORPSOLE | COM | 358.45K | SH | $22.30M 6.79% | 358.45K | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGSSOLE | COM | 570.50K | SH | $20.07M 6.11% | 570.50K | 0.00 | 0.00 |
REGENERON PHARMS.SOLE | COM | 27K | SH | $19.40M 5.91% | 27K | 0.00 | 0.00 |
SUPERNUS PHARMS.SOLE | COM | 523.50K | SH | $15.74M 4.79% | 523.50K | 0.00 | 0.00 |
VERA THERAPEUTICSSOLE | CL A | 975.23K | SH | $15.64M 4.76% | 975.23K | 0.00 | 0.00 |
ALNYLAM PHARMS.SOLE | COM | 81.60K | SH | $15.50M 4.72% | 81.60K | 0.00 | 0.00 |
APELLIS PHARMS.SOLE | COM | 129.70K | SH | $11.81M 3.60% | 129.70K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 52.76K | SH | $11.65M 3.55% | 52.76K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIESSOLE | COM | 176.86K | SH | $11.18M 3.40% | 176.86K | 0.00 | 0.00 |
GILEAD SCIENCESSOLE | COM | 144.58K | SH | $11.14M 3.39% | 144.58K | 0.00 | 0.00 |
ILLUMINA INCSOLE | COM | 50.50K | SH | $9.46M 2.88% | 50.50K | 0.00 | 0.00 |
MIRATI THERAPEUTICS INCSOLE | COM | 260K | SH | $9.39M 2.86% | 260K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 21K | SH | $7.39M 2.25% | 21K | 0.00 | 0.00 |
REVANCE THERAPEUTICS INCSOLE | COM | 288.73K | SH | $7.30M 2.22% | 288.73K | 0.00 | 0.00 |
HORIZON THERAPEUTICSSOLE | SHS | 67K | SH | $6.89M 2.10% | 67K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 441.02K | SH | $6.77M 2.06% | 441.02K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCESSOLE | COM | 68.88K | SH | $6.49M 1.98% | 68.88K | 0.00 | 0.00 |
KARUNA THERAPEUTICS INCSOLE | COM | 25.70K | SH | $5.57M 1.69% | 25.70K | 0.00 | 0.00 |
AURINIA PHARMACEUTICALS INCSOLE | COM | 573.53K | SH | $5.55M 1.69% | 573.53K | 0.00 | 0.00 |
DENALI THERAPEUTICSSOLE | COM | 188K | SH | $5.54M 1.69% | 188K | 0.00 | 0.00 |
KRYSTAL BIOTECHSOLE | COM | 45.95K | SH | $5.39M 1.64% | 45.95K | 0.00 | 0.00 |
BIOMARIN PHARM.SOLE | COM | 58.66K | SH | $5.08M 1.55% | 58.66K | 0.00 | 0.00 |
MADRIGAL PHARMS.SOLE | COM | 18.30K | SH | $4.23M 1.29% | 18.30K | 0.00 | 0.00 |
AXSOME THERAPEUTICSSOLE | COM | 58.30K | SH | $4.19M 1.27% | 58.30K | 0.00 | 0.00 |
Page 1 of 3